Modulating Inflammatory And Fibrogenic Pathways In Kidney Disease Using A Novel Antagonist Of Protease-Activated-Receptor-2
Funder
National Health and Medical Research Council
Funding Amount
$581,116.00
Summary
Chronic kidney disease (CKD) now affects 10% of adults in industrialised countries. Current treatments are largely ineffective. Thus developing better CKD treatments will have substantial public health benefit. Three well established and clinically relevant animal models of kidney disease will be used to test the ability of a new experimental anti-inflammatory drug, developed by members of this research team at The University of Queensland, to prevent or lessen the progression of CKD.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE160100218
Funder
Australian Research Council
Funding Amount
$840,000.00
Summary
A Nuclear Magnetic Resonance Facility for Modern Molecular Analysis. A nuclear magnetic resonance facility for modern molecular analysis:
This project aims to network a new 500 MHz nuclear magnetic resonance (NMR) spectrometer and new consoles for existing instruments with an automated sample changer for a 600 MHz NMR spectrometer. This designed to increase the capacity of Queensland-based researchers to undertake state-of-the-art studies in chemistry, drug design, and materials science. The ne ....A Nuclear Magnetic Resonance Facility for Modern Molecular Analysis. A nuclear magnetic resonance facility for modern molecular analysis:
This project aims to network a new 500 MHz nuclear magnetic resonance (NMR) spectrometer and new consoles for existing instruments with an automated sample changer for a 600 MHz NMR spectrometer. This designed to increase the capacity of Queensland-based researchers to undertake state-of-the-art studies in chemistry, drug design, and materials science. The new knowledge from these studies may lead to the development of new drugs, new crop protection agents and new photovoltaic materials. Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE120103152
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Development of next generation drugs against Helicobacter pylori. Gastric cancer is the second leading cause of cancer-related death in the world and infection by Helicobacter pylori bacteria is the main cause of this disease. The aim of this project is to develop new approaches to treat Helicobacter pylori infection that will give superior results and lower side effects than available therapies.
Placental nutrient transport shows how complex traits evolve. This project aims to use amino acid transport in the vertebrate placenta as a model to demonstrate how genes are recruited and modified to produce a major organ. Using an innovative combination of a new technology, selected reaction monitoring, and transcriptomic and molecular approaches, plus carefully selected Australian species pairs, this project will study the evolution of a complex trait (placental amino acid transport). The pr ....Placental nutrient transport shows how complex traits evolve. This project aims to use amino acid transport in the vertebrate placenta as a model to demonstrate how genes are recruited and modified to produce a major organ. Using an innovative combination of a new technology, selected reaction monitoring, and transcriptomic and molecular approaches, plus carefully selected Australian species pairs, this project will study the evolution of a complex trait (placental amino acid transport). The project will provide fundamental advances in our knowledge of the nutrient transport during pregnancy that is required to produce a healthy baby.Read moreRead less
Cellular Regulation Of Receptor Signalling And Cytokine Responses
Funder
National Health and Medical Research Council
Funding Amount
$859,288.00
Summary
Cell surface receptors and signalling pathways elicit the release of cytokines, or chemical messengers, to control inflammation, which is the body’s response to infection or danger. We have discovered a new signalling pathway that can turn off inflammation and help prevent inflammatory disease. Our studies will now define the molecular details of this pathway and show how new and existing drugs targeting this pathway can be optimally used to treat inflammation and cancer.
Multi-service assessment of intertidal treatment wetlands. This project aims to investigate the use of constructed intertidal wetlands to reduce nitrogen pollution while providing co-benefits including carbon sequestration and biodiversity. This research will generate a holistic assessment of the services, disservices, and cost-effectiveness of intertidal treatment wetlands compared to traditional wastewater treatment approaches. Expected outcomes include a full-scale multi-disciplinary environm ....Multi-service assessment of intertidal treatment wetlands. This project aims to investigate the use of constructed intertidal wetlands to reduce nitrogen pollution while providing co-benefits including carbon sequestration and biodiversity. This research will generate a holistic assessment of the services, disservices, and cost-effectiveness of intertidal treatment wetlands compared to traditional wastewater treatment approaches. Expected outcomes include a full-scale multi-disciplinary environmental and economic assessment of a constructed treatment wetland in a new urban development, providing industry and government partners the knowledge required to broaden uptake of intertidal wetlands as a cost-effective solution to growing levels of coastal anthropogenic pollution.Read moreRead less
CKD-FIX: A Randomised, Controlled Trial Of Allopurinol In The Slowing Of Kidney Disease Progression
Funder
National Health and Medical Research Council
Funding Amount
$1,917,147.00
Summary
Chronic kidney disease (CKD) is a major public health problem affecting over 1.5 million Australians and is associated with increased risk of death, heart disease and progression to end-stage kidney disease (ESKD). Current treatments to slow progression to ESKD are limited. The CKD-FIX trial aims to find out whether treatment with allopurinol, a commonly used drug for gout prevention, safely and effectively slows CKD progression. This could lead to significant health and economic benefits.
A new source of bivalent molecules from nature. This project aims to describe a new class of naturally occurring multivalent molecules termed secreted cysteine-rich repeat proteins (SCREPs). Multivalency is a key feature of molecular interaction in biology, underlying the high specificity and potency found in many proteins. Focusing on bivalent peptides, the project will generate a database of bioactive SCREPs with similarity to known bioactive peptides, and develop new recombinant methods for t ....A new source of bivalent molecules from nature. This project aims to describe a new class of naturally occurring multivalent molecules termed secreted cysteine-rich repeat proteins (SCREPs). Multivalency is a key feature of molecular interaction in biology, underlying the high specificity and potency found in many proteins. Focusing on bivalent peptides, the project will generate a database of bioactive SCREPs with similarity to known bioactive peptides, and develop new recombinant methods for their production. The project will use advanced nuclear magnetic resonance spectroscopy to characterise members of this new class, providing new insights into the design of bivalent and multivalent peptides and establishing a new source of molecules with applications in the rapidly growing biotechnology sector.Read moreRead less